Kazeminy Assad J 4
4 · Lucy Scientific Discovery, Inc. · Filed Feb 15, 2023
Insider Transaction Report
Form 4
Kazeminy Assad J
Chief Scientific Officer
Transactions
- Other
Common Shares
2023-02-13$2.40/sh+85,000$204,000→ 85,000 total(indirect: By LLC)
Footnotes (2)
- [F1]These common shares were issued AJK Biopharmaceutical LLC ("AJK") pursuant to a debt settlement with the Issuer in satisfaction of approximately $204,000 due to AJK in consulting fees.
- [F2]The securities are held by AJK Biopharmaceutical LLC ("AJK"). The reporting person is the sole member of AJK. The reporting persons disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.